Instituto de Investigaci\u00f3n Sanitaria Illes Balears (IdISBa)<\/a> en colaboraci\u00f3n con investigadores de la Universidad de Barcelona ha publicado un estudio sobre las diferencias sexuales en la respuesta antidepresiva inducida por el compuesto 12d, un (3-fenilcarbamoil-3,4-dihidro-2-hir-2hidro-2H-pir de imidazolina-2.<\/p>","protected":false},"excerpt":{"rendered":"El grupo de Neurofarmacolog\u00eda del IUNICS-UIB y del\u00a0Instituto de Investigaci\u00f3n Sanitaria Illes Balears (IdISBa) en colaboraci\u00f3n con investigadores de la Universidad de Barcelona ha publicado un estudio sobre las diferencias sexuales en la respuesta antidepresiva inducida por el compuesto 12d, un (3-fenilcarbamoil-3,4-dihidro-2-hir-2hidro-2H-pir de imidazolina-2.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[5],"tags":[],"class_list":["post-198981","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"\n
Diferencias de sexo en la respuesta antidepresiva a nivel precl\u00ednico del compuesto 12d, un nuevo f\u00e1rmaco con afinidad por el receptor de imidazolina-2 - bip4ex<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Diferencias de sexo en la respuesta antidepresiva a nivel precl\u00ednico del compuesto 12d, un nuevo f\u00e1rmaco con afinidad por el receptor de imidazolina-2\" \/>\n<meta property=\"og:description\" content=\"El grupo de Neurofarmacolog\u00eda del IUNICS-UIB y del\u00a0Instituto de Investigaci\u00f3n Sanitaria Illes Balears (IdISBa) en colaboraci\u00f3n con investigadores de la Universidad de Barcelona ha publicado un estudio sobre las diferencias sexuales en la respuesta antidepresiva inducida por el compuesto 12d, un (3-fenilcarbamoil-3,4-dihidro-2-hir-2hidro-2H-pir de imidazolina-2.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/\" \/>\n<meta property=\"og:site_name\" content=\"bip4ex\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-24T06:17:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1030.jpg\" \/>\n<meta name=\"author\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\\\/\"},\"author\":{\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\"},\"headline\":\"Diferencias de sexo en la respuesta antidepresiva a nivel precl\u00ednico del compuesto 12d, un nuevo f\u00e1rmaco con afinidad por el receptor de imidazolina-2\",\"datePublished\":\"2026-02-24T06:17:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\\\/\"},\"wordCount\":77,\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1030.jpg\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\\\/\",\"name\":\"Diferencias de sexo en la respuesta antidepresiva a nivel precl\u00ednico del compuesto 12d, un nuevo f\u00e1rmaco con afinidad por el receptor de imidazolina-2 - bip4ex\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1030.jpg\",\"datePublished\":\"2026-02-24T06:17:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1030.jpg\",\"contentUrl\":\"https:\\\/\\\/www.infosalut.com\\\/images\\\/noticies\\\/cc\\\/cc-epr1030.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diferencias de sexo en la respuesta antidepresiva a nivel precl\u00ednico del compuesto 12d, un nuevo f\u00e1rmaco con afinidad por el receptor de imidazolina-2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"name\":\"bip4ex\",\"description\":\"Vigilancia Tecnol\u00f3gica\",\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\",\"name\":\"Helloproject.es\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"contentUrl\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"width\":322,\"height\":365,\"caption\":\"Helloproject.es\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\",\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/author\\\/luismi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Diferencias de sexo en la respuesta antidepresiva a nivel precl\u00ednico del compuesto 12d, un nuevo f\u00e1rmaco con afinidad por el receptor de imidazolina-2 - bip4ex","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/","og_locale":"es_ES","og_type":"article","og_title":"Diferencias de sexo en la respuesta antidepresiva a nivel precl\u00ednico del compuesto 12d, un nuevo f\u00e1rmaco con afinidad por el receptor de imidazolina-2","og_description":"El grupo de Neurofarmacolog\u00eda del IUNICS-UIB y del\u00a0Instituto de Investigaci\u00f3n Sanitaria Illes Balears (IdISBa) en colaboraci\u00f3n con investigadores de la Universidad de Barcelona ha publicado un estudio sobre las diferencias sexuales en la respuesta antidepresiva inducida por el compuesto 12d, un (3-fenilcarbamoil-3,4-dihidro-2-hir-2hidro-2H-pir de imidazolina-2.","og_url":"https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/","og_site_name":"bip4ex","article_published_time":"2026-02-24T06:17:42+00:00","og_image":[{"url":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1030.jpg","type":"","width":"","height":""}],"author":"Luis Miguel Mej\u00edas Ramos","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Luis Miguel Mej\u00edas Ramos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/#article","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/"},"author":{"name":"Luis Miguel Mej\u00edas Ramos","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca"},"headline":"Diferencias de sexo en la respuesta antidepresiva a nivel precl\u00ednico del compuesto 12d, un nuevo f\u00e1rmaco con afinidad por el receptor de imidazolina-2","datePublished":"2026-02-24T06:17:42+00:00","mainEntityOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/"},"wordCount":77,"publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1030.jpg","articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/","url":"https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/","name":"Diferencias de sexo en la respuesta antidepresiva a nivel precl\u00ednico del compuesto 12d, un nuevo f\u00e1rmaco con afinidad por el receptor de imidazolina-2 - bip4ex","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/#website"},"primaryImageOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/#primaryimage"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1030.jpg","datePublished":"2026-02-24T06:17:42+00:00","breadcrumb":{"@id":"https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/#primaryimage","url":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1030.jpg","contentUrl":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1030.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/helloproject.es\/vigilancia\/diferencias-de-sexo-en-la-respuesta-antidepresiva-a-nivel-preclinico-del-compuesto-12d-un-nuevo-farmaco-con-afinidad-por-el-receptor-de-imidazolina-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/helloproject.es\/vigilancia\/"},{"@type":"ListItem","position":2,"name":"Diferencias de sexo en la respuesta antidepresiva a nivel precl\u00ednico del compuesto 12d, un nuevo f\u00e1rmaco con afinidad por el receptor de imidazolina-2"}]},{"@type":"WebSite","@id":"https:\/\/helloproject.es\/vigilancia\/#website","url":"https:\/\/helloproject.es\/vigilancia\/","name":"bip4ex","description":"Vigilancia Tecnol\u00f3gica","publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/helloproject.es\/vigilancia\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/helloproject.es\/vigilancia\/#organization","name":"Helloproject.es","url":"https:\/\/helloproject.es\/vigilancia\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/","url":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","contentUrl":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","width":322,"height":365,"caption":"Helloproject.es"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca","name":"Luis Miguel Mej\u00edas Ramos","url":"https:\/\/helloproject.es\/vigilancia\/author\/luismi\/"}]}},"_links":{"self":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/198981","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/comments?post=198981"}],"version-history":[{"count":0,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/198981\/revisions"}],"wp:attachment":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/media?parent=198981"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/categories?post=198981"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/tags?post=198981"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![](\"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1030.jpg\")
<\/p>\n